![Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial]()
Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trialJin, Jie; Wang, Jian-Xiang; Chen, Fei-Fei; Wu, De-Pei; Hu, Jiong; Zhou, Jian-Feng; Hu, Jian-Da; Wang, Jian-Min; Li, Jian-Yong; Huang, Xiao-Jun; Ma, Jun; Ji, Chun-Yan; Xu, Xiao-Ping; Yu, Kang; Ren, Han-Yun; Zhou, Yu-Hong; Tong, Yin; Lou, Yin-Jun; Ni, Wan-Mao; Tong, Hong-Yan; Wang, Hua-Feng; Mi, Ying-Chang; Du, Xin; Chen, Bao-An; Shen, Yi; Chen, Zhu; Chen, Sai-Juan · The Lancet Oncology · 2013